NYSE · Healthcare · Medical Instruments & Supplies · USA
Avantor Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Instruments & Supplies industry.
Avantor provides mission-critical products and services to customers in biopharma and healthcare, education and government, and advanced technologies sectors. Through its VWR channel, the company distributes consumables and equipment to laboratories worldwide, while manufacturing proprietary offerings including high-purity chemicals, fluid handling systems, and silicone materials for medical devices.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Avantor Inc stock.
Overvalued: intrinsic value $3.73 per share, market price $16.05, margin of safety -330.2% (as of 2026-10-30).
Its through-the-cycle earnings (10.0% median margin), capitalised at 8.7% with no growth, values the shares at $3.73; the price of $16.05 is 330% above that value.
Leak Score: 34/100 on 11 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 51 Medical Instruments & Supplies stocks
18 more in this industry show a wider margin of safety.
AVTR is overvalued (as of the 2026-10-30 close). Its through-the-cycle earnings (10.0% median margin), capitalised at 8.7% with no growth, values the shares at $3.73; the price of $16.05 is 330% above that value.
$3.73 per share (as of the 2026-10-30 close), against a market price of $16.05. That is a margin of safety of -330.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
34 out of 100, which we rate "On Watch", on 11 of 12 value investing signals.